764058 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
406 Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: a phase II, single-arm, exploratory research |
2021-11-01 |
10.1136/jitc-2021-sitc2021.406 |
Ma Jianqun, Zhang Jinfeng, Yang Yingnan, Zheng Dayong, Wang Xiaoyuan, Liang Hao, Zhang Luquan, Xin Yanzhong, Ling Xiaodong, Fang Chengyuan, Jiang Hao, Zheng Wei |
764057 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
404 Initial biomarker and clinical data of a phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: cohort of subjects with checkpoint inhibitor-naïve advanced MSS-colorectal cancer |
2021-11-01 |
10.1136/jitc-2021-sitc2021.404 |
Kim Richard, Barve Minal, Mamdani Hirva, Johnson Melissa, Lee Byung Ha, Ferrando-Martinez Sara, Chaney Marya, Fan Jean, Le NgocDiep, Naing Aung |
764056 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
378 Efficacy, safety and ancillary analyses of pembrolizumab in combination with nintedanib for the treatment of patients with relapsed advanced mesothelioma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.378 |
Danlos Francois-Xavier, Baldini Capucine, Texier Matthieu, Varga Andreea, Mouraud Severine, Job Bastien, Letourneur Diane, Cassard Lydie, Bredel Delphine, Laghouati Salim, Adam Julien, Droin Nathalie, Parpaleix Aurelien, Chaput-Gras Nathalie, Rabeau Audrey, Zalcman Gerard, Planchard David, Massard Christophe, Soria Jean-Charles, Marabelle Aurelien |
764055 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
375 Development of thrombospondin-1 as a clinical pharmacodynamic biomarker for VT1021, a first-in-class therapeutic agent that reprograms the tumor microenvironment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.375 |
Chen Jian, Crochiere Marsha, Vincent Melanie, Wang Suming, Fyfe Susanne, Li Wendy, Deng Simai, Watnick Randolph, Watnick Jing, Cieslewicz Michael |
764054 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
374 A phase IB trial of ziv-aflibercept plus pembrolizumab in patients with advanced solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.374 |
Tyan Kevin, Rahma Osama, Giobbie-Hurder Anita, Brohl Andrew, Bedard Philippe, Renouf Daniel, Sharon Elad, Streicher Howard, Hathaway Emma, Cunningham Rachel, Manos Michael, Severgnini Mariano, Rodig Scott, Stephen Hodi F |
764053 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
373 Enhancement of TCR-engineered T-cells targeting MAGE-A4 antigen by co-expression of CD8α and inhibition of AKT signaling during ex vivo T-cell expansion |
2021-11-01 |
10.1136/jitc-2021-sitc2021.373 |
Schmidt Emily, Mardilovich Katerina, Bath Natalie, Betts Gareth, Spinner William, Sun Kathryn, Donaldson Ian, McAlpine Cheryl, Luke Raymond, Navenot Jean-Marc, Sanderson Joseph, Bassett Phil, Evans Chris, Miller Karen, Lin Quan, Dudley Mark, Tipping Alex |
764052 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
371 Analysis of changes in plasma cytokine levels in response to IL-12 therapy in three clinical trials |
2021-11-01 |
10.1136/jitc-2021-sitc2021.371 |
Schwarz Emily, Benner Brooke, Yu Lianbo, Carson William |
764051 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
368 Consistent pattern of immune activation induced by oncolytic adenovirus ONCOS-102 across diverse types of solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.368 |
Kuryk Lukasz, Moller Anne-Sophie, Kumar Sandeep, Shoushtari Alexander, Ares Luis Paz, Jaderberg Magnus, Wiklund Erik Digman, Levitsky Victor |
764050 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
385 Identification and enrichment of neoantigen-reactive T cells to optimize adoptive cell transfer with tumor-infiltrating lymphocytes (TIL) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.385 |
Hall MacLean, Branthoover Holly, Beatty Matthew, Twumasi-Boateng Kwame, Bender Jim, Ceccarelli Jake, Langer TJ, Teer Jamie, Sarnaik Amod, Pilon-Thomas Shari |
764049 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
907 Modulation of tumor immunogenicity by DNA methylation of immune synapse genes in cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.907 |
Hamaidi Imene, Berglund Anders, Mills Matthew, Putney Ryan, Mule James, Kim Sungjune |